To include your compound in the COVID-19 Resource Center, submit it here.

MLN4924: Phase I data

A Phase I trial in 35 patients with advanced solid tumors showed that MLN4924

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE